E-LIB Suche - Ergebnisse für: Remke, M

1

P10.07.A A CLINICALLY COMPATIBLEIN VITRODRUG-SCREENING PLAT..:

Jeising, S ; Trübel, J ; Felsberg, J...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii63-ii63 , 2023

Link: https://doi.org/10.1093/..

2

The development of a hiPSC-based platform to identify tissu..:

Mehjardi, N. Z. ; Kessler, J. ; Sanin, A. Y....
Cell Death Discovery. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

3

C.5 Musashi-1 is a master regulator of aberrant translation..:

Kameda-Smith, MM ; Zhu, H ; Luo, E...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48 (2021) s3 - p. S19-S19 , 2021

Link: https://doi.org/10.1017/..

4

Longitudinal stability of molecular alterations and drug re..:

Nickel, A.C. ; Picard, D. ; Qin, N....
Biomedicine & Pharmacotherapy. 144 (2021) - p. 112278 , 2021

Link: https://doi.org/10.1016/..

5

18 Peroxiredoxin1 is a therapeutic target in group-3 medull..:

Sajesh, BV. ; Ngoc, OH. ; Omar, R....
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45 (2018) S3 - p. S16-S16 , 2018

Link: https://doi.org/10.1017/..

6

CBF1 is clinically prognostic and serves as a target to blo..:

Maciaczyk, D ; Picard, D ; Zhao, L...
British Journal of Cancer. 117 (2017) 1 - p. 102-112 , 2017

Link: https://doi.org/10.1038/..

7

A compartmentalized phosphoinositide signaling axis at cili..:

Conduit, S E ; Ramaswamy, V ; Remke, M...
Oncogene. 36 (2017) 43 - p. 5969-5984 , 2017

Link: https://doi.org/10.1038/..

8

YB-1 is elevated in medulloblastoma and drives proliferatio..:

Dey, A ; Robitaille, M ; Remke, M...
Oncogene. 35 (2016) 32 - p. 4256-4268 , 2016

Link: https://doi.org/10.1038/..

9

WIP1 modulates responsiveness to Sonic Hedgehog signaling i..:

Wen, J ; Lee, J ; Malhotra, A...
Oncogene. 35 (2016) 42 - p. 5552-5564 , 2016

Link: https://doi.org/10.1038/..

10

MB-03 * FUNCTIONAL CHARACTERIZATION OF NOVEL BIOMARKERS IN ..:

Liang, L. ; Aiken, C. ; McClelland, R....
Neuro-Oncology. 17 (2015) suppl 3 - p. iii20-iii20 , 2015

Link: https://doi.org/10.1093/..

11

MB-36 * WIP1 AUGMENTS SONIC HEDGEHOG (SHH) SIGNALING AND IS..:

Lee, J. ; Buss, M. ; Wen, J....
Neuro-Oncology. 17 (2015) suppl 3 - p. iii28-iii28 , 2015

Link: https://doi.org/10.1093/..

12

MB-02 * SONIC HEDGEHOG INDUCES YB-1 IN A YAP-DEPENDENT MANN..:

Dey, A. ; Robitaille, M. ; Remke, M....
Neuro-Oncology. 17 (2015) suppl 3 - p. iii20-iii20 , 2015

Link: https://doi.org/10.1093/..

13

LG-01 * BRAF MUTATION AND CDKN2A DELETION DEFINE A CLINICAL..:

Mistry, M. ; Zhukova, N. ; Merico, D....
Neuro-Oncology. 17 (2015) suppl 3 - p. iii18-iii18 , 2015

Link: https://doi.org/10.1093/..

14

GE-09 * COMBINED HEREDITARY AND SOMATIC MUTATIONS OF REPLIC..:

Shlien, A. ; Campbell, B. B. ; de Borja, R....
Neuro-Oncology. 17 (2015) suppl 3 - p. iii9-iii9 , 2015

Link: https://doi.org/10.1093/..

15

MB-18 * POST-TRANSLATIONAL REGULATION OF ATOH1: FROM CEREBE..:

Cigna, S. M. ; Forget, A. ; Bihannic, L....
Neuro-Oncology. 17 (2015) suppl 3 - p. iii23-iii23 , 2015

Link: https://doi.org/10.1093/..